Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Total Debt (2016 - 2025)

Historic Total Debt for Mimedx (MDXG) over the last 11 years, with Q3 2025 value amounting to $18.2 million.

  • Mimedx's Total Debt fell 1275.98% to $18.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.2 million, marking a year-over-year decrease of 1275.98%. This contributed to the annual value of $18.8 million for FY2024, which is 6164.89% down from last year.
  • According to the latest figures from Q3 2025, Mimedx's Total Debt is $18.2 million, which was down 1275.98% from $18.5 million recorded in Q2 2025.
  • In the past 5 years, Mimedx's Total Debt registered a high of $49.1 million during Q4 2023, and its lowest value of $18.2 million during Q3 2025.
  • In the last 5 years, Mimedx's Total Debt had a median value of $48.0 million in 2021 and averaged $37.7 million.
  • As far as peak fluctuations go, Mimedx's Total Debt skyrocketed by 103.92% in 2023, and later tumbled by 6164.89% in 2024.
  • Over the past 5 years, Mimedx's Total Debt (Quarter) stood at $48.1 million in 2021, then increased by 0.97% to $48.6 million in 2022, then increased by 1.04% to $49.1 million in 2023, then plummeted by 61.65% to $18.8 million in 2024, then dropped by 3.27% to $18.2 million in 2025.
  • Its last three reported values are $18.2 million in Q3 2025, $18.5 million for Q2 2025, and $18.7 million during Q1 2025.